Nanoparticles for the optical imaging of tumor E-selectin

Neoplasia

Volumn 7, Issue 10, 2005, Pages 904-911

  Funovics, Martin ^a   Montet, Xavier ^b   Reynolds, Fred ^b   Weissleder, Ralph ^b   Josephson, Lee ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

E selectin; Internalization; Lewis lung carcinoma; Nanoparticle; Peptide

Indexed keywords

AMINO CROSSLINKED IRON OXIDE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IRON OXIDE; NANOPARTICLE; TUMOR PROTEIN; UNCLASSIFIED DRUG; CARBOCYANINE; CD31 ANTIGEN; CY5.5 CYANINE DYE; CYANINE DYE 3; EDETIC ACID; INTERLEUKIN 1; NANOMATERIAL; PEPTIDE;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL TRANSPORT; CONTROLLED STUDY; CROSS LINKING; DIAGNOSTIC IMAGING; ENDOTHELIUM CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LEWIS CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN TRANSPORT; UMBILICAL VEIN; ANIMAL; BIOSYNTHESIS; CANCER TRANSPLANTATION; CELL LINE; CELL NUCLEUS; CELL SEPARATION; CHEMISTRY; CONFOCAL MICROSCOPY; CYTOLOGY; ENZYME SPECIFICITY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; MALE; METABOLISM; METHODOLOGY; NANOTECHNOLOGY; PATHOLOGY; PROSTATE TUMOR; SENSITIVITY AND SPECIFICITY; TIME; TUMOR CELL LINE; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIGENS, CD31; CARBOCYANINES; CARCINOMA, LEWIS LUNG; CELL LINE; CELL LINE, TUMOR; CELL NUCLEUS; CELL SEPARATION; E-SELECTIN; EDETIC ACID; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; MALE; MICE; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; NANOSTRUCTURES; NANOTECHNOLOGY; NEOPLASM TRANSPLANTATION; PEPTIDES; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; SUBSTRATE SPECIFICITY; TIME FACTORS; UMBILICAL VEINS;

EID: 33644876062     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.05352     Document Type: Article

References (41)

1. Bevilacqua M, Butcher E, Furie B, Gallatin M, Gimbrone M, Harlan J, et al. (1991). Selectins: a family of adhesion receptors. Cell 67, 233.
2. McEver RP (1997). Selectin-carbohydrate interactions during inflammation and metastasis. Glycoconj J 14, 585-591.
3. Stoolman LM (1989). Adhesion molecules controlling lymphocyte migration. Cell 56, 907-910.
4. Phillips ML, Nudelman E, Gaeta FC, Perez M, Singhal AK, Hakomori S, et al. (1990). ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science 250, 1130-1132.
5. Haskard DO, Keelan ET, Chapman PT, Robinson M, Binns RM, Jamar F, et al. (1998). Quantifying and imaging activated endothelium in inflammation. Endothel Cell Res Ser 4, 135-149.
6. Bevilacqua MP, Stengelin S, Gimbrone MA Jr, and Seed B (1989). Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 243, 1160-1165.
7. Fukuda MN, Ohvama C, Lowitz K, Matsuo O, Pasqualini R, Ruoslahti E, et al. (2000). A peptide mimic of E-selectin ligand inhibits sialyl Lewis X- dependent lung colonization of tumor cells. Cancer Res 60, 450-456.
8. Zetter BR (1993). Adhesion molecules in tumor metastasis. Semin Cancer Biol 4, 219-229.
9. Brodt P, Fallavollita L, Bresalier RS, Meterissian S, Norton CR, and Wolitzky BA (1997). Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis. Int J Cancer 71, 612-619.
10. Perez JM, Josephson L, O'Loughlin T, Hogemann D, and Weissleder R (2002). Magnetic relaxation switches capable of sensing molecular interactions. Nat Biotechnol 20, 816-820.
11. Josephson L, Perez JM, and Weissleder R (2001). Magnetic nanosensors for the detection of oligonucleotide sequences. Angew Chem Int Ed Engl 40, 3204-3206.
12. Josephson L, Tung CH, Moore A, and Weissleder R (1999). High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem 10, 186-191.
13. Zinn KR, Chaudhuri TR, Smyth CA, Wu Q, Liu H-G, Fleck M, Mountz JD, and Mountz JM (1999). Specific targeting of activated endothelium in rat adjuvant arthritis with a 99mTc-radiolabeled E-selectin-binding peptide. Arthritis Rheum 42, 641-649.
14. Martens CL, Cwirla SE, Lee RYW, Whitehorn E, Chen EYF, Bakker A, Martin EL, Wagstrom C, Gopalan P, and Smith CW (1995). Peptides which bind to E-selectin and block neutrophil adhesion. J Biol Chem 270, 21129-21136.
15. Hammel M, Weitz-Schmidt G, Krause A, Moll T, Vestweber D, Zerwes HG, et al. (2001). Species-specific and conserved epitopes on mouse and human E-selectin important for leukocyte adhesion. Exp Cell Res 269, 266-274.
16. Kang HW, Josephson L, Petrovsky A, Weissleder R, Bogdanov A Jr (2002). Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture. Bioconjug Chem 13, 122-127.
17. Spragg DD, Alford DR, Greferath R, Larsen CE, Lee KD, Gurtner GC, Cybulsky MI, Tosi PF, Nicolau C, and Gimbrone MA Jr (1997). Immunotargeting of liposomes to activated vascular endothelial cells: a strategy for site-selective delivery in the cardiovascular system. Proc Natl Acad Sci USA 94, 8795-8800.
18. Koch AM, Reynolds F, Kircher MF, Merkle HP, Weissleder R, and Josephson L (2003). Uptake and metabolism of a dual fluorochrome Tat-nanoparticle in HeLa cells. Bioconjug Chem 14, 1115-1121.
19. Schellenberger EA, Reynolds F, Weissleder R, and Josephson L (2004). Surface-functionalized nanoparticle library yields probes for apoptotic cells. ChemBioChem 5, 275-279.
20. Reynolds F, O'Loughlin T, Weissleder R, and Josephson L (2005). Method of determining nanoparticle core weight. Anal Chem 77, 814-817.
21. Kelly KA, Reynolds F, Weissleder R, and Josephson L (2004). FITC-hapten immunoassay for determination of peptide-cell interactions. Anal Biochem 330, 181-185.
22. Mahmood U, Tung CH, Bogdanov A Jr, and Weissleder R (1999). Near-infrared optical imaging of protease activity for tumor detection. Radiology 213, 866-870.
23. Mahmood U, Tung CH, Tang Y, and Weissleder R (2002). Feasibility of in vivo multichannel optical imaging of gene expression: experimental study in mice. Radiology 224, 446-451.
24. Allport JR and Weissleder R (2003). Murine Lewis lung carcinoma-derived endothelium expresses markers of endothelial activation and requires tumor-specific extracellular matrix in vitro. Neoplasia 5, 205-217.
25. Wunderbaldinger P, Josephson L, and Weissleder R (2002). Tat peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticles. Bioconjug Chem 13, 264-268.
26. Bhaskar V, Law DA, Ibsen E, Breinberg D, Cass KM, DuBridge RB, et al. (2003). E-selectin up-regulation allows for targeted drug delivery in prostate cancer. Cancer Res 63, 6387-6394.
27. Ferrucci JT and Stark DD (1990). Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years. AJR Am J Roentgenol 155, 943-950.
28. Chen F, Ward J, and Robinson PJ (1999). MR imaging of the liver and spleen: a comparison of the effects on signal intensity of two super-paramagnetic iron oxide agents. Magn Reson Imaging 17, 549-556.
29. Chachuat A and Bonnemain B (1995). European clinical experience with Endorem. A new contrast agent for liver MRI in 1000 patients. Radiologie 35, S274-S276.
30. Seneterre E, Taourel P, Bouvier Y, Pradel J, Van Beers B, Daures JP, et al. (1996). Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 200, 785-792.
31. Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, de la Rosette J, and Weissleder R (2003). Non-invasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348, 2491-2499.
32. Gellissen J, Axmann C, Prescher A, Bohndorf K, and Lodemann KP (1999). Extra- and intracellular accumulation of ultrasmall superparamagnetic iron oxides (USPIO) in experimentally induced abscesses of the peripheral soft tissues and their effects on magnetic resonance imaging. Magn Reson Imaging 17, 557-567.
33. Kaim AH, Wischer T, O'Reilly T, Jundt G, Frohlich J, von Schulthess GK, and Allegrini PR (2002). MR imaging with ultrasmall superparamagnetic iron oxide particles in experimental soft-tissue infections in rats. Radiology 225, 808-814.
34. Ruehm SG, Corot C, Vogt P, Kolb S, and Debatin JF (2001). Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 103, 415-422.
35. Schmitz SA, Taupitz M, Wagner S, Wolf KJ, Beyersdorff D, and Hamm B (2001). Magnetic resonance imaging of atherosclerotic plaques using superparamagnetic iron oxide particles. J Magn Reson Imaging 14, 355-361.
36. Trivedi R, J U-King-Im, and Gillard J (2003). Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaque. Circulation 108, e140 (author reply e140).
37. Dardzinski BJ, Schmithorst VJ, Holland SK, Boivin GP, Imagawa T, Watanabe S, et al. (2001). MR imaging of murine arthritis using ultra-small superparamagnetic iron oxide particles. Magn Reson Imaging 19, 1209-1216.
38. Enochs WS, Harsh G, Hochberg F, and Weissleder R (1999). Improved delineation of human brain tumors on MR images using a long- circulating, superparamagnetic iron oxide agent. J Magn Reson Imaging 9, 228-232.
39. Kircher MF, Allport JR, Graves EE, Love V, Josephson L, Lichtman AH, and Weissleder R (2003). In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res 63, 6838-6846.
40. Jonkmanns C, Saleh A, Rees M, and Moedder U (2002). Ultrasmall superparamagnetic iron oxide MIR of head and neck cancer: enhancement of primary tumor and influence on T staging. Radiology 225 (supplement), 281.
41. von Asmuth EJ, Smeets EF, Ginsel LA, Onderwater JJ, Leeuwenberg JF, and Buurman WA (1992). Evidence for endocytosis of E-selectin in human endothelial cells. Eur J Immunol 22, 2519-2526.